Experimental Nuclear Medicine Meets Tumor Biology

Personalized treatment of cancer patients demands specific and validated biomarkers for tumor diagnosis and therapy. The development and validation of such require translational preclinical models that recapitulate human diseases as accurately as possible. Moreover, there is a need for convergence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Balber, Theresa, Tran, Loan, Benčurová, Katarína, Raitanen, Julia, Egger, Gerda, Mitterhauser, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878163/
https://www.ncbi.nlm.nih.gov/pubmed/35215337
http://dx.doi.org/10.3390/ph15020227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878163/
https://www.ncbi.nlm.nih.gov/pubmed/35215337
http://dx.doi.org/10.3390/ph15020227

Ejemplares similares